Crimean-Congo Hemorrhagic Fever Virus Monoclonal Antibodies: A Work In Progress

A recent study on Crimean-Congo Hemorrhagic Fever Virus may pave the way for a new monoclonal antibody treatment in the near future.

Source: Forbes.com Healthcare News - December 1, 2022 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news